What is the recommended weight‑based prophylactic dose of cefalexin for infants with urinary tract infection, including dosing for neonates (0‑6 weeks) versus older infants (up to 12 months) and adjustments for renal impairment?

Cefalexin Prophylaxis Dosing for Urinary Tract Infection in Infants

Standard Prophylactic Dose

For UTI prophylaxis in infants beyond the neonatal period (>6 weeks to 12 months), administer cefalexin 10-12.5 mg/kg once daily at bedtime. 1, 2

• The single evening dose provides adequate urinary concentrations (500-1000 mcg/mL) throughout the night when bacterial multiplication is highest, far exceeding the minimum inhibitory concentration for common uropathogens 3, 4
• This once-daily regimen improves adherence compared to multiple daily dosing while maintaining efficacy 2

Age-Specific Considerations

Neonates (0-6 weeks)

• Cefalexin is not recommended for neonatal UTI prophylaxis due to lack of safety and efficacy data in this age group 3
• Alternative agents such as ampicillin (50 mg/kg/day divided every 12 hours for infants <7 days and <1200 g; 75 mg/kg/day divided every 8 hours for infants >7 days and >1500 g) should be considered 5

Older Infants (6 weeks to 12 months)

• Standard prophylactic dose: 10-12.5 mg/kg once daily at bedtime 1, 2
• Children have greater body water turnover and may require higher per-kilogram doses than adults to achieve equivalent tissue concentrations 3
• The drug is rapidly absorbed in the upper intestine and does not disturb lower bowel flora 3

Renal Impairment Adjustments

For infants with creatinine clearance <30 mL/min, reduce the cefalexin dose by 50% or extend the dosing interval to every 48 hours. 3

• Cefalexin is 70-100% renally excreted unchanged within 6-8 hours 3
• Dose reduction should be proportional to reduced renal function as determined by creatinine clearance 3
• Monitor serum creatinine regularly in infants with known or suspected renal impairment 3

Alternative Prophylactic Agents

When cefalexin is contraindicated or ineffective:

• Cefaclor 5-10 mg/kg/day (divided 1-3 times daily depending on age) has demonstrated low rates of resistant E. coli and good tolerability 1
• Trimethoprim-sulfamethoxazole at 4 mg/kg trimethoprim plus 20 mg/kg sulfamethoxazole once daily, though increasing resistance patterns limit its use 5, 6
• Nitrofurantoin 5-7 mg/kg/day divided into 4 doses (not approved for infants <12 years in some jurisdictions; use only for uncomplicated UTI, not pyelonephritis) 5

Administration and Monitoring

• Administer as a single evening dose to maximize overnight urinary concentrations when bacterial growth is most active 2
• Cefalexin achieves urinary concentrations of 500-1000 mcg/mL following standard prophylactic doses, providing substantial antimicrobial activity against common uropathogens 3, 4
• The drug demonstrates low protein binding and no measurable metabolism, with predictable pharmacokinetics 3

Common Pitfalls to Avoid

• Do not use cefalexin in neonates <6 weeks due to insufficient safety data in this population 3
• Avoid multiple daily dosing when once-daily evening administration provides equivalent efficacy with better adherence 2
• Do not use standard adult doses in infants, as children require weight-based dosing adjusted for their higher body water turnover 3
• Failure to adjust for renal impairment (CrCl <30 mL/min) risks drug accumulation and toxicity 3
• Do not use for organisms with documented cefalexin resistance, including Enterococcus, Morganella, and Pseudomonas species 1